MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Price & Overview
EPA:ALMKT • FR0010609263
Current stock price
The current stock price of ALMKT.PA is 0.1852 EUR. Today ALMKT.PA is down by -2.01%. In the past month the price increased by 6.07%. In the past year, price increased by 128.64%.
ALMKT.PA Key Statistics
- Market Cap
- 35.577M
- P/E
- N/A
- Fwd P/E
- 3.00
- EPS (TTM)
- -0.16
- Dividend Yield
- N/A
ALMKT.PA Stock Performance
ALMKT.PA Stock Chart
ALMKT.PA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ALMKT.PA. When comparing the yearly performance of all stocks, ALMKT.PA is one of the better performing stocks in the market, outperforming 97.6% of all stocks.
ALMKT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA. Both the profitability and financial health of ALMKT.PA have multiple concerns.
ALMKT.PA Earnings
ALMKT.PA Forecast & Estimates
10 analysts have analysed ALMKT.PA and the average price target is 0.36 EUR. This implies a price increase of 92.76% is expected in the next year compared to the current price of 0.1852.
ALMKT.PA Groups
Sector & Classification
ALMKT.PA Financial Highlights
Over the last trailing twelve months ALMKT.PA reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -114.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMKT.PA Ownership
ALMKT.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.19 | 94.93B | ||
| 2M6 | MEDTRONIC PLC | 13.71 | 91.72B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.17 | 42.932B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.12 | 23.524B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.97 | 23.496B | ||
| BIM | BIOMERIEUX | 18.49 | 10.723B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 20.07 | 3.814B | ||
| DIA | DIASORIN SPA | 15.45 | 3.547B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.73 | 2.495B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.84 | 1.808B | ||
| DRW8 | DRAEGERWERK AG | 9.2 | 1.403B | ||
| ELN | EL.EN. SPA | 17.76 | 1.076B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.7 | 963.598M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALMKT.PA
Company Profile
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
Company Info
IPO: 2011-07-05
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE FR
Employees: 61
Phone: 33148240345
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What does MAUNA KEA TECHNOLOGIES do?
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
What is the stock price of MAUNA KEA TECHNOLOGIES today?
The current stock price of ALMKT.PA is 0.1852 EUR. The price decreased by -2.01% in the last trading session.
What is the dividend status of MAUNA KEA TECHNOLOGIES?
ALMKT.PA does not pay a dividend.
What is the ChartMill technical and fundamental rating of ALMKT stock?
ALMKT.PA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in MAUNA KEA TECHNOLOGIES be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALMKT.PA.
Can you provide the growth outlook for MAUNA KEA TECHNOLOGIES?
The Revenue of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is expected to decline by 0% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.